Search Results - "Shlyakhto, Valeria"

NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis by Kreutmair, Stefanie, Lippert, Lena Johanna, Klingeberg, Cathrin, Albers-Leischner, Corinna, Yacob, Salome, Shlyakhto, Valeria, Mueller, Tony, Mueller-Rudorf, Alina, Yu, Chuanjiang, Gorantla, Sivahari Prasad, Miething, Cornelius, Duyster, Justus, Illert, Anna Lena

“…The NPM-ALK fusion kinase is expressed in 60% of systemic anaplastic large-cell lymphomas (ALCL). A Nuclear Interaction Partner of ALK (NIPA) was identified as…”
Get full text

Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation by Alber, David, Rummelt, Christoph, Strüßmann, Tim, Rettig, Andrés, Shlyakhto, Valeria, La Rosée, Paul, Henkes, Martin, Bubnova, Elizaveta, Ma, Tobias, Thomas, Johanna, Ihorst, Gabriele, Wehr, Claudia, Marks, Reinhard, Becker, Heiko, Duyster, Justus, Wäsch, Ralph, Finke, Jürgen, Lübbert, Michael

“…Background DNA-hypomethylating agents (HMAs) have improved the prognosis of patients (pts) with acute myeloid leukemia (AML) unfit for standard induction…”
Get full text

Optimizing Early Prediction Of Outcome In CML Using The Exact Decline Of BCR-ABL Transcript Levels Within 3 Months Of Imatinib Treatment As a Prognostic Marker by Hanfstein, Benjamin, Shlyakhto, Valeria, Lauseker, Michael, Hehlmann, Rüdiger, Saussele, Susanne, Erben, Philipp, Dietz, Christian, Fabarius, Alice, Proetel, Ulrike, Schnittger, Susanne, Krause, Stefan W., Schubert, Jörg, Einsele, Hermann, Hänel, Mathias, Dengler, Jolanta, Falge, Christiane, Kanz, Lothar, Neubauer, Andreas, Kneba, Michael, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Baerlocher, Gabriela M., Pfirrmann, Markus, Hasford, Joerg, Hofmann, Wolf-Karsten, Hochhaus, Andreas, Müller, Martin C.

“…Early assessment of BCR-ABL transcript levels at 3 months allows the prediction of survival and may serve as a trigger for treatment intensification in CML…”
Get full text

Absolute BCR-ABL Transcript Levels At 3 Months but Not At Diagnosis Predict Survival of Chronic Myeloid Leukemia (CML) Patients On Imatinib Therapy by Hanfstein, Benjamin, Shlyakhto, Valeria, Lauseker, Michael, Erben, Philipp, Saussele, Susanne, Fabarius, Alice, Proetel, Ulrike, Schnittger, Susanne, Kolb, Hans-Jochem, Krause, Stefan W., Schubert, Joerg, Einsele, Hermann, Hänel, Mathias, Dengler, Jolanta, Falge, Christiane, Kanz, Lothar, Neubauer, Andreas, Kneba, Michael, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Baerlocher, Gabriela M., Pfirrmann, Markus, Hasford, Joerg, Hofmann, Wolf-Karsten, Hehlmann, Rüdiger, Hochhaus, Andreas, Müller, Martin C.

“…Abstract 3761 Early assessment of molecular and cytogenetic response at 3 months of imatinib treatment has been shown to predict survival and might trigger…”
Get full text